Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.069 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |